AI is seen as a promising tool for improving clinical, operational, and financial aspects of healthcare, though its impact remains largely theoretical for now. This article reviews current progress, outlines strategies for success, and emphasizes balancing innovation with responsibility to ensure benefits for both patients and clinicians.
Learning Objectives
Review current progress, outline strategies for success, and emphasize balancing innovation with responsibility.
Examine benefits for both patients and clinicians.
Article Authors
Thomas F. Deering, MBA, MD, FHRS, CCDS, Andrew D. Krahn, MD, FHRS, Jodie L. Hurwitz, MD, FHRS
Podcast Contributors
Krishna Pundi, MD, Stanford University/Palo Alto VA Medical Center
Tina Baykaner, MD, MPH, Stanford University
Jason G. Andrade, MD, FHRS, Vancouver General Hospital
Faculty and Disclosures
All relevant financial relationships have been mitigated.
Contributor Disclosure(s):
J. Andrade:
Honoraria/Speaking/Consulting: Medtronic, Biosense Webster, Inc., Boston Scientific
T. Baykaner:
Honoraria/Speaking/Consulting: Volta Medical, Medtronic, Pacemate, Johnson and Johnson, Abbott Medical, Boston Scientific
Research: NIH
K. Pundi:
Nothing to disclose.
Resource Type
- Podcasts
Related Resources
The Lead
Podcasts
The Lead Episode 153: A Discussion of Exercise Capacity and Quality-of-Life Improvements after Catheter Ablation in Patients with Clinically Asymptomatic Persistent Atrial Fibrillation
May 28, 2026
The Lead
Podcasts
The Lead Episode 151: Heart Rhythm 2026 Late-Breaker Coverage: A Discussion of Outcomes of Left Atrial Appendage Closure versus Oral Anticoagulation in Patients with Atrial Fibrillation and Prior Ablation: A Sub-Analysis of the CHAMPION-AF Clinical Trial
May 21, 2026
The Lead
Podcasts
The Lead Episode 152: A Discussion of Outcomes of Left Atrial Appendage Closure versus Oral Anticoagulation in Patients with Atrial Fibrillation and Prior Ablation: A Sub-Analysis of the CHAMPION-AF Clinical Trial (NEJM)
May 21, 2026